Victory Square Technologies Launches DiscreetCare – a Full-Service Web App for the Treatment of Sensitive & Delicate Medical Issues
Victory Square Technologies has launched DiscreetCare, a telehealth platform aimed at addressing sensitive health issues like hair loss and erectile dysfunction. Phase 1 includes treatments for various conditions, while Phase 2 will expand testing services. The service enhances user convenience by allowing private consultations with licensed physicians through a web app. DiscreetCare aims to reduce treatment avoidance due to stigma and discomfort associated with traditional in-person appointments. The company is poised to capitalize on the growing telehealth trend in the U.S.
- DiscreetCare addresses a niche market by offering treatment for sensitive conditions.
- Convenient and discreet access to medical care enhances user experience.
- Phase 2 expansion includes additional testing and treatment options, fostering growth.
- None.
VANCOUVER, British Columbia, May 25, 2021 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. ("Victory Square'' or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) announces the launch of DiscreetCare (https://discreetcare.com/) across the United States, as part of its multi-phase expansion into the rapidly growing Telehealth category.
Phase 1 of the DiscreetCare.com web app focuses on treating Hair Loss, Erectile Dysfunction, Premature Ejaculation, Genital Herpes, Cold Sores, Acne, and Bladder Control issues.
Phase 2, launching later this year, will offer at-home testing for STDs, Testosterone and Fertility; as well as treatment for a broader range of sensitive medical issues.
Victory Square Technologies CEO, Shafin Diamond Tejani said, “The vision for DiscreetCare is to be a one-stop provider for what many consider ‘delicate’ medical issues. Our web app gives users access to testing, treatment and prescriptive medicinal remedies - all from the convenience and privacy of one’s mobile device.”
The Company notes that convenience is one of many benefits offered to users of DiscreetCare. DiscreetCare also offers doctor evaluations, and FDA-approved medications with competitive pricing.
VS Digital Health Vice President of Marketing, Binu Koshy, explains, “By offering a service that is both discreet and convenient, we are providing healthcare solutions to those who until now, have chosen ‘avoidance’ over action when it comes to their overall wellbeing. Koshy adds, “Think of that 20-something who just started losing his hair but is too embarrassed to seek treatment, or that 30-year-old with Erectile Dysfunction (ED) who avoids seeking important medical offerings because the Viagra and Cialis commercials typically show and sell to men who are 20 years older.”
DiscreetCare Medical Director, Dr. Jeremy Roebuck adds, “Booking an appointment, sitting in a public waiting room and having an awkward face to face conversation are all roadblocks that contribute to the issue of ‘avoidance’ when it comes to individuals seeking treatment for embarrassing awkward or socially stigmatized conditions.”
DiscreetCare provides an easier and less invasive alternative for its clients… they simply:
1) Log onto to DiscreetCare.com using your computer or mobile device
2) Answer a series of medical questions which will be reviewed by a licensed physician,
3) Receive your medication in discreet packaging within 2 to 4 days.
4) Follow-up with your doctor, pharmacist or DiscreetCare support if you have any additional questions or concerns
For users wanting a more personal touch or in-depth medical consultation, DiscreetCare will be offering private virtual appointments with a certified doctor from the Company’s vast network of physicians across all 50 states.
Dr. Roebuck explains, “Other digital care platforms provide pre-determined selections assuming the user knows their medical issue. With DiscreetCare, patients can explain symptoms so the doctor can determine their specific condition and prescribe appropriate treatment for the client. For example, a new skin rash could be one of many things, from eczema to psoriasis to a symptom of a more serious underlying condition.”
The COVID-19 pandemic has resulted in more and more people being comfortable receiving medical care from the convenience of their home, turning the concept of Telehealth from a service for early adopters to a fixture across the United States. With the development of their Telehealth platform and nationwide clinician network, Victory Square Technologies has positioned themselves to capitalize on this emerging trend - whether it be further expansion of their own niche services or providing an all-in-one solution for businesses looking to license a white-label virtual care platform and clinician network.
On behalf of the Board of Directors
“Shafin Diamond Tejani”
Director and Chief Executive Officer
Victory Square Technologies Inc.
www.victorysquare.com
For further information about Victory Square, please contact:
Investor Relations
Contact – Edge Communications Group
Email: ir@victorysquare.com
Telephone: 604 283-9166
Media Relations
Contact – Howard Blank, Director
Email: howard@victorysquare.com
Telephone: 604-928-6066
ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth. VST's sweet spot is cutting-edge tech that's shaping the 4th Industrial Revolution. Our corporate portfolio consists of 20 global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.
What we do differently for startups
VST isn't your ordinary investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.
What we do differently for investors
VST is a publicly-traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF). For investors, we offer early-stage access to the next unicorns before they're unicorns. Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies. Because we focus on market-ready solutions that scale quickly, we're able to provide strong and stable returns while also tapping into emerging global trends with big upsides.
For more information, please visit www.victorysquare.com
Forward Looking Statement
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects, offerings and opportunities of Victory Square and its related subsidiaries including VS Digital Health Inc., DiscreetCare.com and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
FAQ
What is DiscreetCare by Victory Square Technologies?
What conditions does DiscreetCare treat?
When will Phase 2 of DiscreetCare launch?
How does DiscreetCare ensure patient convenience?
What is the stock symbol for Victory Square Technologies?
